WO2024261183A1 - Electrochemical oxidation of compounds having allylic c-h bonds to yield alpha,beta-unsaturated ketones - Google Patents
Electrochemical oxidation of compounds having allylic c-h bonds to yield alpha,beta-unsaturated ketones Download PDFInfo
- Publication number
- WO2024261183A1 WO2024261183A1 PCT/EP2024/067339 EP2024067339W WO2024261183A1 WO 2024261183 A1 WO2024261183 A1 WO 2024261183A1 EP 2024067339 W EP2024067339 W EP 2024067339W WO 2024261183 A1 WO2024261183 A1 WO 2024261183A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- formula
- process according
- compound
- methyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 49
- 238000006056 electrooxidation reaction Methods 0.000 title claims abstract description 29
- 150000002576 ketones Chemical class 0.000 title claims abstract description 7
- 125000000746 allylic group Chemical group 0.000 title abstract description 3
- 238000000034 method Methods 0.000 claims abstract description 52
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 34
- 150000002148 esters Chemical class 0.000 claims abstract description 19
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 17
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims abstract description 15
- INBGSXNNRGWLJU-ZHHJOTBYSA-N 25-hydroxycholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCCC(C)(C)O)C)[C@@]1(C)CC2 INBGSXNNRGWLJU-ZHHJOTBYSA-N 0.000 claims abstract description 14
- INBGSXNNRGWLJU-UHFFFAOYSA-N 25epsilon-Hydroxycholesterin Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(CCCC(C)(C)O)C)C1(C)CC2 INBGSXNNRGWLJU-UHFFFAOYSA-N 0.000 claims abstract description 14
- ORNBQBCIOKFOEO-YQUGOWONSA-N Pregnenolone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC3)C[C@@H](O)CC4)CC2)CC1 ORNBQBCIOKFOEO-YQUGOWONSA-N 0.000 claims abstract description 13
- 229960000249 pregnenolone Drugs 0.000 claims abstract description 13
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims abstract description 11
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims abstract description 11
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 claims abstract description 8
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims abstract description 8
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims abstract description 8
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 claims abstract description 8
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 claims abstract description 8
- 235000004420 brassicasterol Nutrition 0.000 claims abstract description 8
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims abstract description 8
- 235000000431 campesterol Nutrition 0.000 claims abstract description 8
- 229950005143 sitosterol Drugs 0.000 claims abstract description 8
- IOWMKBFJCNLRTC-XWXSNNQWSA-N (24S)-24-hydroxycholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](O)C(C)C)[C@@]1(C)CC2 IOWMKBFJCNLRTC-XWXSNNQWSA-N 0.000 claims abstract description 7
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims abstract description 7
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000016831 stigmasterol Nutrition 0.000 claims abstract description 7
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims abstract description 7
- 229940032091 stigmasterol Drugs 0.000 claims abstract description 7
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims abstract description 7
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 claims abstract description 6
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 claims abstract description 6
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 claims abstract description 6
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 claims abstract description 6
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 claims abstract description 6
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 claims abstract description 6
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 claims abstract description 6
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 claims abstract description 6
- 229940058690 lanosterol Drugs 0.000 claims abstract description 6
- -1 tetrafluoroborate Chemical compound 0.000 claims description 30
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 125000006239 protecting group Chemical group 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 12
- OZZAYJQNMKMUSD-DMISRAGPSA-N pregnenolone succinate Chemical compound C1C=C2C[C@@H](OC(=O)CCC(O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 OZZAYJQNMKMUSD-DMISRAGPSA-N 0.000 claims description 11
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 9
- XUGISPSHIFXEHZ-UHFFFAOYSA-N 3beta-acetoxy-cholest-5-ene Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XUGISPSHIFXEHZ-UHFFFAOYSA-N 0.000 claims description 9
- XUGISPSHIFXEHZ-VEVYEIKRSA-N cholesteryl acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XUGISPSHIFXEHZ-VEVYEIKRSA-N 0.000 claims description 9
- YEYCQJVCAMFWCO-UHFFFAOYSA-N 3beta-cholesteryl formate Natural products C1C=C2CC(OC=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 YEYCQJVCAMFWCO-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 7
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical class C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- CRRKVZVYZQXICQ-RJJCNJEVSA-N Pregnenolone acetate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H](C(C)=O)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 CRRKVZVYZQXICQ-RJJCNJEVSA-N 0.000 claims description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- 229910001495 sodium tetrafluoroborate Inorganic materials 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 5
- UVZUFUGNHDDLRQ-LLHZKFLPSA-N cholesteryl benzoate Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)C(=O)C1=CC=CC=C1 UVZUFUGNHDDLRQ-LLHZKFLPSA-N 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 229910052723 transition metal Inorganic materials 0.000 claims description 5
- BNXZHVUCNYMNOS-UHFFFAOYSA-N 1-butylpyrrolidin-2-one Chemical compound CCCCN1CCCC1=O BNXZHVUCNYMNOS-UHFFFAOYSA-N 0.000 claims description 4
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- 150000001447 alkali salts Chemical class 0.000 claims description 4
- 239000003125 aqueous solvent Substances 0.000 claims description 4
- 229960001760 dimethyl sulfoxide Drugs 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 150000002978 peroxides Chemical class 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 150000001204 N-oxides Chemical class 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- 239000011356 non-aqueous organic solvent Substances 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 claims description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 abstract description 4
- 229940076810 beta sitosterol Drugs 0.000 abstract 1
- ORNBQBCIOKFOEO-QGVNFLHTSA-N pregnenolone Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 ORNBQBCIOKFOEO-QGVNFLHTSA-N 0.000 abstract 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000003115 supporting electrolyte Substances 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 7
- 239000003223 protective agent Substances 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 235000011149 sulphuric acid Nutrition 0.000 description 5
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 3
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 3
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 3
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 3
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 3
- 229910021397 glassy carbon Inorganic materials 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 3
- 229910001486 lithium perchlorate Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 235000015500 sitosterol Nutrition 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 2
- UTRBHXSKVVPTLY-UHFFFAOYSA-N 4,5,6,7-tetrachloro-2-hydroxyisoindole-1,3-dione Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C2=C1C(=O)N(O)C2=O UTRBHXSKVVPTLY-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- 238000005868 electrolysis reaction Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- NSPJNIDYTSSIIY-UHFFFAOYSA-N methoxy(methoxymethoxy)methane Chemical compound COCOCOC NSPJNIDYTSSIIY-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 2
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 2
- MCZDHTKJGDCTAE-UHFFFAOYSA-M tetrabutylazanium;acetate Chemical compound CC([O-])=O.CCCC[N+](CCCC)(CCCC)CCCC MCZDHTKJGDCTAE-UHFFFAOYSA-M 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- BVMGAUOJVUEFSV-UHFFFAOYSA-N 1-(oxan-2-yl)indazol-6-amine Chemical compound C12=CC(N)=CC=C2C=NN1C1CCCCO1 BVMGAUOJVUEFSV-UHFFFAOYSA-N 0.000 description 1
- JOBAYBRAHVTSSW-UHFFFAOYSA-N Campesteryl-acetat Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCC(C)C(C)C)C1(C)CC2 JOBAYBRAHVTSSW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005148 Cholesterol Benzoate Substances 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- QYTDEUPAUMOIOP-UHFFFAOYSA-N TEMPO Chemical group CC1(C)CCCC(C)(C)N1[O] QYTDEUPAUMOIOP-UHFFFAOYSA-N 0.000 description 1
- DAXLMQCSUKIBAW-YYEMIFOZSA-N [(3s,8s,9s,10r,13r,14s,17r)-17-[(2r)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCC(O)C(C)C)[C@@]1(C)CC2 DAXLMQCSUKIBAW-YYEMIFOZSA-N 0.000 description 1
- ZQROOWXJYJXFQN-SPNIRZQASA-N [(3s,8s,9s,10r,13r,14s,17r)-17-[(2r)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] benzoate Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCC(O)C(C)C)C(=O)C1=CC=CC=C1 ZQROOWXJYJXFQN-SPNIRZQASA-N 0.000 description 1
- DSBZSDSUGSYUHV-HSIBUNQISA-N [(3s,8s,9s,10r,13r,14s,17r)-17-[(2r)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCCC(C)(C)O)C)[C@@]1(C)CC2 DSBZSDSUGSYUHV-HSIBUNQISA-N 0.000 description 1
- JOBAYBRAHVTSSW-NTUCOQBPSA-N [(3s,8s,9s,10r,13r,14s,17r)-17-[(2r,5r)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 JOBAYBRAHVTSSW-NTUCOQBPSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- LXFUMTATZMTJID-UHFFFAOYSA-N benzoate de stigmasterile Natural products C1CC2(C)C3CCC4(C)C(C(C)C=CC(CC)C(C)C)CCC4C3CC=C2CC1OC(=O)C1=CC=CC=C1 LXFUMTATZMTJID-UHFFFAOYSA-N 0.000 description 1
- YAXRKAKOIWXVHL-UHFFFAOYSA-N brassicasterol acetate Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 YAXRKAKOIWXVHL-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- 125000003461 pregnenolone group Chemical group 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- IZEUIYYDWBKERE-UHFFFAOYSA-N stigmasteryl acetate Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 IZEUIYYDWBKERE-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B3/00—Electrolytic production of organic compounds
- C25B3/01—Products
- C25B3/07—Oxygen containing compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B3/00—Electrolytic production of organic compounds
- C25B3/20—Processes
- C25B3/23—Oxidation
Definitions
- Electrochemical processes have emerged as environment-friendly methods and sustainable technologies that offer a different solution to many environmental problems because they are versatile, efficient, cost-effective, easily automatable, and the electrons are a clean reagent (inexpensive and suitable reagent to drive the conversion), avoiding conventional chemical oxidizers or reducing agents
- N-hydroxyphthalimide and its derivatives are known as mediator.
- the use of this compound class is highly controversial, leading to the fact that for example the use of tetrachloro-N-hydroxyphthalimide is banned in Europe. Therefore, any oxidation methods without using N-hydroxyphthalimide or derivatives are highly appreciated by the industry and market. Summary of the invention
- the problem to be solved by the present invention is to offer a method of producing specific a,p unsaturated ketones compound from the respective compounds having allylic C-H bonds which allows high yield.
- a key element of this process is the use of t-buty I hydroperoxide. This leads to the advantage, that said process can be performed in the absence of oxygen, hydrogen peroxide or any peroxide different from t-butyl hydroperoxide.
- Said process has an excellent yield and can be performed in such a way that it has big economical as well as ecological advantages and bears low risks of hazard and working safety.
- the present invention relates to a process for preparing a compound of the formula (I) by electrochemical oxidation of a compound of the formula (II)
- R 1 represents either
- Ci -io-alkyl group which optionally is olefinic or carries at least a carbonyl or hydroxyl group
- R 2 represents H
- R 3 and R 4 independently from each other, represent either H or a methyl group
- R 7 and R 8 independently from each other, represent either H or a methyl group
- a “Cx-y-alkyl” group is an alkyl group comprising x to y carbon atoms, i.e. , for example, a Ci-3-alkyl group is an alkyl group comprising 1 to 3 carbon atoms.
- the alkyl group can be linear or branched. For example -CH(CH3)-CH2-CH3 is considered as a C4-alkyl group.
- Any single dotted line in any formulae represents the bond by which said substituent is bound to the rest of a molecule.
- a “non-aqueous solvent” means that no water is included in the solvent on purpose. However, it might be possible that said solvent comprises traces of water (usually below 5 wt.-%, based on the total weight of the solvent). Preferably, a non-aqueous solvent comprises less than 1 % by weight, particularly less than 0.1 % by weight, based on the total weight of the solvent. and of the formula
- the compound of the formula (I) is prepared by electrochemical oxidation of a compound of the formula (II) in the presence of t-butyl hydroperoxide.
- R represents hydrogen or R' which is a protecting group.
- a protecting group is a group which protects the hydroxylic group and the protecting group can be easily removed, i.e. by state-of-the-art methods, resulting to the respective compound with the free hydroxylic group again.
- the protecting group R' is introduced by a chemical reaction of the compound of the respective formula having H as R with a protecting agent.
- the protecting agents leading to the corresponding protecting groups are known to the person skilled in the art, as well as the chemical process and conditions for this reaction. If, for example, the protecting group forms with the rest of the molecule an ester, the suitable protecting agent is for example an acid, an anhydride, or an acyl halide.
- the protecting group R' is particularly selected from the groups consisting of wherein R 31 represent independently from each other a Ci -15-alkyl or a fluorinated Ci-15-alkyl or a Ci-15-cycloalkyl or a C?-i5-aralkyl group;
- R 32 represents a Ci-15-alkylene or a Ce-15-alkylene group; and wherein either
- R 33 represents a Ci -15-alkyl group or an alkyleneoxyalkyl group or a polyoxyalkylene group
- R 34 represents hydrogen or a Ci-15-alkyl group
- R 33 and R 34 represent together a Cs-7-alkylene group forming a 5 to 7 membered ring;
- R 35 and R 36 and R 37 represent independently from each other a Ci-15-alkyl or a fluorinated Ci -15-alkyl or Ce-15-aryl group; and wherein Y 1 represents either hydrogen or a group of the formula and wherein the single dotted line represents the bond by which said substituent is bound to the rest of a molecule.
- the respective compound is an ester of a carboxylic acid or dicarboxylic acid, which can be formed by the reaction of the respective protecting agent with the hydroxylic group.
- R is an Ci-7-acyl, preferably acetyl, trifluoroacetyl, propionyl or benzoyl group, or a substituted benzoyl group.
- Esters can be easily deprotected under the influence of an acid or a base.
- the respective compound is an acetal, which can be formed by the reaction of the respective protecting agent with the hydroxylic group (OH).
- the protecting agent may be for example, a respective aldehyde, alkyl halide, e.g. MeO(CH2)2OCH2CI, or an enol ether, e.g. 3,4-dihydro- 2H- pyran.
- the substituent Ft' is preferably
- acetals are also called “ethers”, particularly in the cases mentioned above: methoxymethyl ether (MOM-ether), p-methoxyethoxy- methyl ether (MEM-ether) or tetrahydropyranyl ether (THP-ether).
- MOM-ether methoxymethyl ether
- MEM-ether p-methoxyethoxy- methyl ether
- THP-ether tetrahydropyranyl ether
- Acetals can be easily deprotected under the influence of acids.
- the respective compound is an ester of phosphoric acid, pyrophosphoric acid, phosphorous acid, sulphuric acid or sulphurous acid.
- esterification is either complete or partial, leaving some residual acid groups of the respective acid non-esterified.
- the protecting group Ft' is a benzoyl group or a C1-4- acyl group, particularly acetyl or trifluoroacetyl group, more particularly acetyl group.
- the molecules in which Ft' represents an acyl group, particularly an acetyl group, can be easily prepared from the corresponding unprotected molecule by esterification, and the unprotected hydroxylic compound can be obtained from the corresponding ester by ester hydrolysis.
- protecting group Ft' is an acetyl group or a benzoyl group, particularly an acetyl group.
- the compound of the formula (I) and (II) have chirality centers. It is preferred that the compounds of the formula (I), resp. (II) have the following configurations given in formula (l-A) resp. (I l-A)
- R 1 represents either or a Ci -io-alkyl group which optionally is olefinic or carries at least a carbonyl or hydroxyl group.
- R 1 represents OR, wherein R represents H or R' which is a protecting group.
- the dotted line ( ) represents a single bond in the formulae (I) and (II).
- the compound of the formula (II) is either (I l-2a) or (I l-2b)
- R 1 forms a Ci-io-alkyl group which optionally is olefinic or carries at least a carbonyl or hydroxyl group.
- R 1 is a substituent of the formula (III) wherein R 5 represents either H or CHs or CH2CH3 or OH and
- R 6 represents either H or OH; and the bonds having dotted line ( ) in formula (III) represents either a single bond or a double bond; and wherein the single dotted line represents the bond by which said substituent is bound to the rest of a molecule.
- the substituent of the formula (III) is selected from the group consisting of (lll-A),(ll l-B),(ll l-C),(l ll-D), (lll-E), (lll-F), (lll-G), (lll-H), (lll-l) and (lll-J)
- the compound of the formula (II) of this embodiment is selected from the group consisting of cholesterol, stigmasterol, campesterol, 0- sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms, preferably selected from the group consisting of cholesterol, 25-hydroxychole- sterol, cholesteryl acetate, 25-hydroxycholesteryl acetate, cholesteryl acetate, 25- hydroxycholesteryl acetate, cholesteryl benzoate and 25-hydroxycholesteryl benzoate.
- R 1 is a Ci- -alkyl group which carries at least a carbonyl group.
- R 10 is a Ci-w-alkyl group, preferably CH3.
- the compound of the formula (II) of this embodiment is pregnenolone or its esters with a carboxylic acid having 1 to 7 carbon atoms, particularly pregnenolone acetate.
- the compound of the formula (II) is selected from the group consisting of cholesterol, stigmasterol, campesterol, 0-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol, pregnenolone, and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of cholesterol acetate, stigmasterol acetate, campesterol acetate, 0-sitosterol acetate, brassicasterol acetate, 25- hydroxycholesterol acetate, 24-hydroxycholesterol acetate, pregnenolone acetate,; cholesterol benzoate, stigmasterol benzoate, campesterol benzoate, 0- sitosterol benzoate, brassicasterol benzoate, 25-hydroxycholesterol benzoate, 24- hydroxycholesterol benzoate, and pregnenolone benzoate.
- Figure 1 shows the structures of cholesterol, stigmasterol, campesterol, 0- sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol and pregnenolone.
- the compound of the formula (II) is selected from the group consisting of pregnenolone and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of pregnenolone, pregnenolone acetate and pregnenolone benzoate.
- the compound of the formula (II) is selected from the group consisting of cholesterol, pregnenolone, and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of cholesterol, pregnenolone, cholesteryl acetate and pregnenolone acetate, more preferably selected from the group consisting of cholesterol, cholesteryl acetate, and pregnenolone acetate.
- the compound of the formula (II) is selected from the group consisting of cholesterol, stigmasterol, campesterol, 0-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of cholesterol, 25-hydroxycholesterol, cholesteryl acetate, 25-hydroxycholesteryl acetate, cholesteryl acetate, 25- hydroxycholesteryl acetate, cholesteryl benzoate and 25-hydroxycholesteryl benzoate.
- the compound of the formula (II) is selected from the group consisting of cholesterol, stigmasterol, campesterol, 0-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms.
- the compound of the formula (II) is selected from the group consisting of cholesterol, 25-hydroxycholesterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of cholesterol, 25-hydroxycholesterol, cholesteryl acetate, 25- hydroxycholesteryl acetate, cholesteryl benzoate and 25-hydroxycholesteryl benzoate, preferably cholesterol or 25-hydroxycholesterol.
- the compound of the formula (I) is prepared from the compound of the formula (II) as described above in the presence of t-butyl hydroperoxide (by electrochemical oxidization.
- t-Butyl hydroperoxide (CHs)3C-OOH ) is commercially available in large volumes and several suppliers.
- an electrochemical oxidization requires electrodes, i.e. an anode and a cathode.
- the material of the anode and the cathode is not critical and can be any suitable materials known in the art, such as steel, glassy carbon and platinum.
- the material of the electrode is steel, glassy carbon and/or platinum.
- the form and size (which also means the surface area) of the electrodes in the present invention are also not critical. They may be in any size and in any form, such as in a form of a wire, a rod, a cell, a mesh, a grid, a sponge, or any other design suitable for the electrochemical reactor (cell) used in the process of the present invention.
- the electrode is in the form of a wire, a rod, a cell, a mesh, a grid, a sponge, or any other design suitable for the electrochemical reactor (cell).
- an electrochemical oxidization is performed in a cell.
- the cell also known as voltaic cells or galvanic cells, used in the process according to the present invention can be any one of those known by a person skilled in the art. Usually and preferably, it is a two-compartments electrochemical flow-cell.
- the process according to the present invention is carried out preferably in at least one solvent.
- the electrochemical reaction is performed in water or a non-aqueous solvent or mixture thereof, preferably in a non-aqueous organic solvent, particularly selected from the group consisting of alkylene carbonates, dialkylcarbonates, polyethylene glycol, N-methyl-2-pyrrolidone, N-butylpyrrolidone (NBP), alcohols, esters, ketones, particularly acetone and 2-butanone; acetic acid, sulpholane, dimethylsulphoxide (DMSO), tetrahydrofuran (THF), 2-methyl-tetra- hydrofuran (MeTHF), dimethylformamide (DMF), hexa-methylphosphoramide, acetonitrile (MeCN), dichloromethane (DCM), dimethoxyethane (DME) and hexafluoro-2-propanol, and mixtures thereof.
- a non-aqueous organic solvent particularly selected from the group consisting of alkylene carbonates, dialkylcarbonates, polyethylene
- 2-butanone 2-butanone.
- the electrochemical oxidation is preferably performed in the presence of a supporting electrolyte, which may be added to in the form of a salt and/or in form of an acid. Any commonly known and commonly used supporting electrolyte can be used.
- the suitable supporting electrolytes include but are not limited to HCI, H2SO4, Na2SO4, NaCI, NaHSO4, alkyl- or arylsulfonic acids (such as methanesulfonic acid and p-toluenesulfonic acid), phosphoric acid, phosphates, and tetraalkylammonium salts (such as tetrabutylammonium acetate (NBu4OAc), tetrabutylammonium tetrafluoroborate and tetrabutylammonium hexafluorophosphate).
- the supporting electrolyte used in the present invention is an acid such as HCI, H2SO4, phosphoric acid or mixture thereof.
- the supporting electrolyte is selected from the group consisting of HCI, H2SO4, Na2SO4, NaCI, NaHSO4, alkyl- or arylsulfonic acids (such as methanesulfonic acid and p-toluenesulfonic acid), phosphoric acid, phosphates, and tetraalkylammonium salts (such as tetrabutylammonium acetate (NBu4OAc), tetrabutylammonium tetrafluoroborate and tetrabutylammonium hexafluorophosphate), most preferably from the group consisting of HCI, H2SO4 and phosphoric acid.
- alkyl- or arylsulfonic acids such as methanesulfonic acid and p-toluenesulfonic acid
- phosphoric acid such as methanesulfonic acid and p-toluenesulfonic acid
- phosphoric acid such
- Such supporting electrolytes are particularly selected from the water soluble alkali salts, particularly of sodium and lithium.
- the supporting electrolyte is selected from the group of water soluble alkali salts of tetrafluoroborate and perchlorate, particularly lithium perchlorate and sodium tetrafluoroborate.
- the supporting electrolyte is not a perchlorate salt.
- said process is preferably performed in the presence of an alkali salt of tetrafluoroborate, particularly of sodium tetrafluoroborate.
- alkali salts of tetrafluoroborate particularly of sodium tetrafluoroborate.
- the concentration of the supporting electrolyte in the reaction medium is preferably up to 5 mol/L (M), more preferably from 0.01 M to 4 M, even more preferably from 0.01 M to 3 M, the most preferably from 0.01 M to 1 .5 M.
- the compound t-butyl hydroperoxide is commercially available from different sources.
- the compound t- butyl hydroperoxide has a function as an oxygen source. Furthermore, it is believed that t- butyl hydroperoxide has also a mediator function in the electrochemical oxidation process.
- t- butyl hydroperoxide is included in the reaction medium in an amount of from 0.1 vol.-% to 20 vol.-%, preferably from 0.5 vol.-% to 15.0 vol.-%, more preferably from 1 .0 vol.-% to 10 vol.-%, such as 1 vol.-%, 2 vol.-%, 3 vol.-%,
- t-butyl hydroperoxide is included in the reaction medium in an amount of from 1 .0 vol.-% to 10 vol.-%, preferably from 2.0 vol.-% to 7.5 vol.-%, more preferably from 4.0 vol.-% to 6.0 vol.-% such as 4.0 vol.-%, 4.5 vol.-% and 5.0 vol.-%.
- the molar ratio of t-buty I hydroperoxide I compound of the formula (II) is preferably in the range of 1 :1 to 10:1 , more preferably 1.1 :1 to 8:1 , even more preferably 1 .5:1 to 5:1 . It is most preferred that of molar ratio of t-butyl hydroperoxide/compound of formula (II) is 2.5:1 to 4.5:1 .
- the process is performed in the absence of oxygen, hydrogen peroxide or any peroxide different from t-buty I hydroperoxide, parti- cularly in the absence of hydrogen peroxide or any peroxide different from t-butyl hydroperoxide.
- the compound of the formula (II) may be added into the reaction medium preferably in an amount of from 0.1 mmol/L (mM) to 100 mM, preferably from 0.2 mM to 75 mM, more preferably from 0.2 mM to 50 mM.
- the transferred charge (Q) for the electrochemical oxidation is preferably 10 Faraday (F) or less.
- F Faraday
- a suitable range is particularly 1 -15 F, preferred is 1.5-10 F; more preferred is 1.5-9 F; most preferred is 1 .5-8 F such as 2, 3, 4, 5, 6, 7 and 8 F.
- the current density (/) used in the electrochemical oxidation may be preferably from 0.1 mA/cm 2 to 100 mA/cm 2 , preferably from 0.3 mA/cm 2 to 50 mA/cm 2 , preferably from 0.5 mA/cm 2 to 20 mA/cm 2 .
- the described electrochemical oxidation can be carried out in Galvano- static or potentiostatic mode.
- the electrochemical oxidation according to the present invention can be carried out batch-wise, semi-batch-wise, or in a continuous way, preferably in a continuous way.
- the electrochemical oxidation is preferably carried out in galvanostatic mode.
- the electrochemical oxidation is preferably carried out in potentiostatic mode
- the electrochemical oxidation is preferably carried out carried out batch-wise.
- the electrochemical oxidation is preferably carried out carried out batch-wise.
- the electrochemical oxidation is preferably carried out carried out semi-batch-wise.
- the electrochemical oxidation is preferably carried out carried out in a continuous way.
- the electrochemical oxidation is preferably carried out at a temperature range of from 10 °C to 75 °C, preferably from 15 °C to 60 °C, more preferably at ambient temperature (23°C).
- the electrochemical oxidation is preferably carried out at ambient pressure (1013 hPa).
- said process is preferably performed in the presence of a base, particularly in the presence of an organic base, most preferably in the presence of pyridine.
- the molar ratio of pyridine/compound of formula (II) is in the range of 1 :1 to 10:1 , more preferably 1 .1 :1 to 8:1 , even more preferably 1 .5:1 to 5:1 . It is most preferred that of molar ratio of pyridine/compound of formula (II) is 2.5:1 to 3.5:1 .
- N-oxide derivatives such as TEMPO ((2,2,6,6-tetramethyl- piperidin-1 -yl)oxyl) or N-hydroxyphthalimide derivatives.
- TEMPO (2,2,6,6-tetramethyl- piperidin-1 -yl)oxyl
- N-hydroxyphthalimide derivatives are highly controversial and, leading to the fact that for example the use of tetrachloro-N-hydroxyphthalimide is banned in Europe.
- the big advantage that the electrochemical oxidation can be performed as described above, particularly in the absence of a variety of substances, which are typically required to be present for electrochemical oxidations, is significant as only a low number of ingredients need to be mixed, and the different ingredients of a less complex mixture can be can separated more easily from a reaction mixture after that the reaction has occurred, particularly when the reaction has such high conversion, yield and selectivity as enabled by the present process.
- the present invention relates the use of t-buty I hydroperoxide in the electrochemical oxidation of a compound of the formula (II).
- the present invention is further illustrated by the following experiments.
- the undivided Teflon cells used for electrolysis were purchased from IKA (IKA-Werke GmbH & Co. KG, Staufen, Germany).
- the dimensions of the electrodes are 7 cm x 1 cm x 0.3 cm.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to the electrochemical oxidation of allylic C- H bonds in specific compounds to obtain specific α,β unsaturated ketones in the presence of t-butyl hydroperoxide. This process is particularly suitable for the electrochemical oxidation of cholesterol, stigmasterol, campesterol, β-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol, pregnenolone, and the esters thereof.
Description
Background of the invention
Electrochemical processes have emerged as environment-friendly methods and sustainable technologies that offer a different solution to many environmental problems because they are versatile, efficient, cost-effective, easily automatable, and the electrons are a clean reagent (inexpensive and suitable reagent to drive the conversion), avoiding conventional chemical oxidizers or reducing agents
To oxidise allylic compound, the prior art discloses a variety of ways such as photochemical process or using strong oxidizing agents.
So far, only a few electrochemical or electrocatalytic processes for allylic C-H oxidation are known, wherein the conditions are not ideal and/or the yields are not good. An electrochemical mediator is needed, which makes the reaction mixture even more complex.
Particularly, N-hydroxyphthalimide and its derivatives, particularly tetra- chloro-N-hydroxyphthalimide, are known as mediator. However, the use of this compound class is highly controversial, leading to the fact that for example the use of tetrachloro-N-hydroxyphthalimide is banned in Europe. Therefore, any oxidation methods without using N-hydroxyphthalimide or derivatives are highly appreciated by the industry and market.
Summary of the invention
Therefore, the problem to be solved by the present invention is to offer a method of producing specific a,p unsaturated ketones compound from the respective compounds having allylic C-H bonds which allows high yield.
Surprisingly, it has been found the process according to claim 1 offers a solution to this problem.
A key element of this process is the use of t-buty I hydroperoxide. This leads to the advantage, that said process can be performed in the absence of oxygen, hydrogen peroxide or any peroxide different from t-butyl hydroperoxide.
It has been particularly found that this process can be performed in the absence of any additional mediator, particularly in the absence of N-oxide derivatives or N-hydroxyphthalimide derivatives.
Furthermore, it has been found that said process can be performed in the absence of any transition metals salts.
Said process has an excellent yield and can be performed in such a way that it has big economical as well as ecological advantages and bears low risks of hazard and working safety.
Further aspects of the invention are subject of further independent claims. Particularly preferred embodiments are subject of dependent claims.
Detailed description of the invention
In a first aspect the present invention relates to a process for preparing a compound of the formula (I) by electrochemical oxidation of a compound of the formula (II)
R1 represents either
OR or a Ci -io-alkyl group which optionally is olefinic or carries at least a carbonyl or hydroxyl group; and
R2 represents H;
R3 and R4, independently from each other, represent either H or a methyl group;
R7 and R8, independently from each other, represent either H or a methyl group;
R represents hydrogen or R' which is a protecting group; and with the proviso that if R7 = R8 = methyl the double bond in formula (I) and
For sake of clarity, some terms used in the present document are defined as follows:
In the present document, a “Cx-y-alkyl” group is an alkyl group comprising x to y carbon atoms, i.e. , for example, a Ci-3-alkyl group is an alkyl group comprising 1 to 3 carbon atoms. The alkyl group can be linear or branched. For example -CH(CH3)-CH2-CH3 is considered as a C4-alkyl group.
In case identical labels for symbols or groups are present in several formulae, in the present document, the definition of said group or symbol made in the context of one specific formula applies also to other formulae which comprises the same said label.
The term “independently from each other” in this document means, in the context of substituents, moieties, or groups, that identically designated substituents, moieties, or groups can occur simultaneously with a different meaning in the same molecule.
Any single dotted line in any formulae represents the bond by which said substituent is bound to the rest of a molecule.
In this document a “non-aqueous solvent” means that no water is included in the solvent on purpose. However, it might be possible that said solvent comprises traces of water (usually below 5 wt.-%, based on the total weight of the solvent). Preferably, a non-aqueous solvent comprises less than 1 % by weight, particularly less than 0.1 % by weight, based on the total weight of the solvent.
and of the formula
The compound of the formula (I) is prepared by electrochemical oxidation of a compound of the formula (II) in the presence of t-butyl hydroperoxide.
R represents hydrogen or R' which is a protecting group.
A protecting group is a group which protects the hydroxylic group and the protecting group can be easily removed, i.e. by state-of-the-art methods, resulting to the respective compound with the free hydroxylic group again.
The protecting group R' is introduced by a chemical reaction of the compound of the respective formula having H as R with a protecting agent.
The protecting agents leading to the corresponding protecting groups are known to the person skilled in the art, as well as the chemical process and conditions for this reaction. If, for example, the protecting group forms with the rest of the molecule an ester, the suitable protecting agent is for example an acid, an anhydride, or an acyl halide.
The protecting group R' is particularly selected from the groups consisting of
wherein R31 represent independently from each other a Ci -15-alkyl or a fluorinated Ci-15-alkyl or a Ci-15-cycloalkyl or a C?-i5-aralkyl group;
R32 represents a Ci-15-alkylene or a Ce-15-alkylene group; and wherein either
R33 represents a Ci -15-alkyl group or an alkyleneoxyalkyl group or a polyoxyalkylene group;
R34 represents hydrogen or a Ci-15-alkyl group; or
R33 and R34 represent together a Cs-7-alkylene group forming a 5 to 7 membered ring;
R35 and R36 and R37 represent independently from each other a Ci-15-alkyl or a fluorinated Ci -15-alkyl or Ce-15-aryl group; and wherein Y1 represents either hydrogen or a group of the formula
and wherein the single dotted line represents the bond by which said substituent is bound to the rest of a molecule.
If R' is represented by
, the respective compound is an ester of a carboxylic acid or dicarboxylic acid, which can be formed by the reaction of the respective protecting agent with the hydroxylic group.
If the compound of the respective formula is an ester of a carboxylic acid or dicarboxylic acid, it is preferred that R is an Ci-7-acyl, preferably acetyl, trifluoroacetyl, propionyl or benzoyl group, or a substituted benzoyl group.
Esters can be easily deprotected under the influence of an acid or a base.
the respective compound is an acetal, which can be formed by the reaction of the respective protecting agent with the hydroxylic group (OH). In this case, the protecting agent may be for example, a respective aldehyde, alkyl halide, e.g. MeO(CH2)2OCH2CI, or an enol ether, e.g. 3,4-dihydro- 2H- pyran.
In some instances, acetals are also called “ethers”, particularly in the cases mentioned above: methoxymethyl ether (MOM-ether), p-methoxyethoxy- methyl ether (MEM-ether) or tetrahydropyranyl ether (THP-ether).
Acetals can be easily deprotected under the influence of acids.
In another embodiment, the respective compound is an ester of phosphoric acid, pyrophosphoric acid, phosphorous acid, sulphuric acid or sulphurous acid.
Depending on the reaction conditions, the esterification is either complete or partial, leaving some residual acid groups of the respective acid non-esterified.
It is most preferred that the protecting group Ft' is a benzoyl group or a C1-4- acyl group, particularly acetyl or trifluoroacetyl group, more particularly acetyl group. The molecules in which Ft' represents an acyl group, particularly an acetyl group, can be easily prepared from the corresponding unprotected molecule by esterification, and the unprotected hydroxylic compound can be obtained from the corresponding ester by ester hydrolysis.
Most preferably protecting group Ft' is an acetyl group or a benzoyl group, particularly an acetyl group.
The compound of the formula (I) and (II) have chirality centers. It is preferred that the compounds of the formula (I), resp. (II) have the following configurations given in formula (l-A) resp. (I l-A)
As mentioned above, in case R7 = R8 = methyl, the double bond in formula (I) and (II) is switched its position to the formula (I’) and (II’). In said case, it is preferred that the compounds of the formula (I’), resp. (II’) have the following configurations given in formula (I’-A) resp. (H’-A)
The groups R3 and R4, independently from each other, represent either H or a methyl group. It is preferred that groups R3 = R4 = CH3.
R7 and R8, independently from each other, represent either H or a methyl group. It is preferred that R7 = R8, particularly preferred that R7 = R8 = CH3.
R2 represents either H.
R1 represents either
or a Ci -io-alkyl group which optionally is olefinic or carries at least a carbonyl or hydroxyl group.
In a first embodiment, R1 represents OR, wherein R represents H or R' which is a protecting group.
In a second, most preferred, embodiment, R1 forms a Ci-io-alkyl group which optionally is olefinic or carries at least a carbonyl or hydroxyl group.
Preferably, R1 is a substituent of the formula (III)
wherein R5 represents either H or CHs or CH2CH3 or OH and
R6 represents either H or OH; and the bonds having dotted line ( ) in formula (III) represents either a single bond or a double bond; and
wherein the single dotted line represents the bond by which said substituent is bound to the rest of a molecule.
Some of the carbon atoms in the substituent of the formula (III) are chiral. It is preferred that they have the following the following configurations given in formula (Ill-chiral)
It is preferred that only one of the bonds having dotted lines ( ) in formula (III) and (Ill-chiral) is a carbon-carbon double bond.
In case that (III) or (Ill-chiral) has a double carbon-carbon bond, it is preferred that it is in the E- configuration.
More specifically, the substituent of the formula (III) is selected from the group consisting of (lll-A),(ll l-B),(ll l-C),(l ll-D), (lll-E), (lll-F), (lll-G), (lll-H), (lll-l) and (lll-J)
It is preferred that the compound of the formula (II) of this embodiment is selected from the group consisting of cholesterol, stigmasterol, campesterol, 0- sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms, preferably selected from the group consisting of cholesterol, 25-hydroxychole- sterol, cholesteryl acetate, 25-hydroxycholesteryl acetate, cholesteryl acetate, 25- hydroxycholesteryl acetate, cholesteryl benzoate and 25-hydroxycholesteryl benzoate.
In a further embodiment, R1 is a Ci- -alkyl group which carries at least a carbonyl group.
It is particularly preferred that the compound of the formula (II) of this embodiment is pregnenolone or its esters with a carboxylic acid having 1 to 7 carbon atoms, particularly pregnenolone acetate.
It is preferred that the compound of the formula (II) is selected from the group consisting of cholesterol, stigmasterol, campesterol, 0-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol, pregnenolone, and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of cholesterol acetate, stigmasterol acetate, campesterol acetate, 0-sitosterol acetate, brassicasterol acetate, 25-
hydroxycholesterol acetate, 24-hydroxycholesterol acetate, pregnenolone acetate,; cholesterol benzoate, stigmasterol benzoate, campesterol benzoate, 0- sitosterol benzoate, brassicasterol benzoate, 25-hydroxycholesterol benzoate, 24- hydroxycholesterol benzoate, and pregnenolone benzoate.
Figure 1 shows the structures of cholesterol, stigmasterol, campesterol, 0- sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol and pregnenolone.
It is particularly preferred that the compound of the formula (II) is selected from the group consisting of pregnenolone and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of pregnenolone, pregnenolone acetate and pregnenolone benzoate.
In one embodiment, it is particularly preferred, that the compound of the formula (II) is selected from the group consisting of cholesterol, pregnenolone, and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of cholesterol, pregnenolone, cholesteryl acetate and pregnenolone acetate, more preferably selected from the group consisting of cholesterol, cholesteryl acetate, and pregnenolone acetate.
It is even more preferred that the compound of the formula (II) is selected from the group consisting of cholesterol, stigmasterol, campesterol, 0-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of cholesterol, 25-hydroxycholesterol, cholesteryl acetate, 25-hydroxycholesteryl acetate, cholesteryl acetate, 25- hydroxycholesteryl acetate, cholesteryl benzoate and 25-hydroxycholesteryl benzoate.
It is even more preferred that the compound of the formula (II) is selected from the group consisting of cholesterol, stigmasterol, campesterol, 0-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms.
Most preferably, the compound of the formula (II) is selected from the group consisting of cholesterol, 25-hydroxycholesterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of cholesterol, 25-hydroxycholesterol, cholesteryl acetate, 25- hydroxycholesteryl acetate, cholesteryl benzoate and 25-hydroxycholesteryl benzoate, preferably cholesterol or 25-hydroxycholesterol.
It is evident to person skilled in the art that the respective oxidation product of the above preferred compounds (II) is the respective a,p unsaturated ketone of the formula (I). The configuration at the chirality centers remains unchanged by the electrochemical oxidation reaction.
The compound of the formula (I) is prepared from the compound of the formula (II) as described above in the presence of t-butyl hydroperoxide (by electrochemical oxidization. t-Butyl hydroperoxide ( (CHs)3C-OOH ) is commercially available in large volumes and several suppliers.
Electrochemical reaction
The process of the present invention to oxidise the compound of formula (II) has great advantages such as
Electricity as a safe and cost-effective oxidizing agent
Simplified method for electrochemical allylic oxidation
Reaction conditions suitable for industry-relevant scaling of the approaches
Dual functionality of oxygen source and mediator
Avoidance of brittle, unwieldy electrode material
Avoidance of potentially explosive conductive salts
Elimination of cost-intensive catalytic converter systems
As known by the person skilled in the art, an electrochemical oxidization requires electrodes, i.e. an anode and a cathode.
In the present invention, the material of the anode and the cathode is not critical and can be any suitable materials known in the art, such as steel, glassy carbon and platinum.
Preferably, the material of the electrode is steel, glassy carbon and/or platinum.
The form and size (which also means the surface area) of the electrodes in the present invention are also not critical. They may be in any size and in any form, such as in a form of a wire, a rod, a cell, a mesh, a grid, a sponge, or any other design suitable for the electrochemical reactor (cell) used in the process of the present invention.
Preferably, the electrode is in the form of a wire, a rod, a cell, a mesh, a grid, a sponge, or any other design suitable for the electrochemical reactor (cell).
As known by the person skilled in the art, an electrochemical oxidization is performed in a cell.
The cell, also known as voltaic cells or galvanic cells, used in the process according to the present invention can be any one of those known by a person skilled in the art. Usually and preferably, it is a two-compartments electrochemical flow-cell.
The process according to the present invention is carried out preferably in at least one solvent.
It is preferred that the electrochemical reaction is performed in water or a non-aqueous solvent or mixture thereof, preferably in a non-aqueous organic solvent, particularly selected from the group consisting of alkylene carbonates, dialkylcarbonates, polyethylene glycol, N-methyl-2-pyrrolidone, N-butylpyrrolidone (NBP), alcohols, esters, ketones, particularly acetone and 2-butanone; acetic acid, sulpholane, dimethylsulphoxide (DMSO), tetrahydrofuran (THF), 2-methyl-tetra- hydrofuran (MeTHF), dimethylformamide (DMF), hexa-methylphosphoramide, acetonitrile (MeCN), dichloromethane (DCM), dimethoxyethane (DME) and hexafluoro-2-propanol, and mixtures thereof.
Particularly preferred is acetonitrile (=MeCN) and 2-butanone (=methyl ethyl ketone = MEK). Most preferred is 2-butanone.
The electrochemical oxidation is preferably performed in the presence of a supporting electrolyte, which may be added to in the form of a salt and/or in form of an acid. Any commonly known and commonly used supporting electrolyte can be used. Examples of the suitable supporting electrolytes include but are not limited to HCI, H2SO4, Na2SO4, NaCI, NaHSO4, alkyl- or arylsulfonic acids (such as methanesulfonic acid and p-toluenesulfonic acid), phosphoric acid, phosphates, and tetraalkylammonium salts (such as tetrabutylammonium acetate (NBu4OAc), tetrabutylammonium tetrafluoroborate and tetrabutylammonium hexafluorophosphate). Preferably, the supporting electrolyte used in the present invention is an acid such as HCI, H2SO4, phosphoric acid or mixture thereof.
It is preferred that the supporting electrolyte is selected from the group consisting of HCI, H2SO4, Na2SO4, NaCI, NaHSO4, alkyl- or arylsulfonic acids (such as methanesulfonic acid and p-toluenesulfonic acid), phosphoric acid, phosphates, and tetraalkylammonium salts (such as tetrabutylammonium acetate (NBu4OAc), tetrabutylammonium tetrafluoroborate and tetrabutylammonium hexafluorophosphate), most preferably from the group consisting of HCI, H2SO4 and phosphoric acid.
It is preferred to add some salts as supporting electrolytes. Such supporting electrolytes are particularly selected from the water soluble alkali salts, particularly of sodium and lithium.
It is preferred that the supporting electrolyte is selected from the group of water soluble alkali salts of tetrafluoroborate and perchlorate, particularly lithium perchlorate and sodium tetrafluoroborate.
Due to the process hazards, it is preferred that the supporting electrolyte is not a perchlorate salt.
It has been, furthermore, found that said process is preferably performed in the presence of an alkali salt of tetrafluoroborate, particularly of sodium tetrafluoroborate. These salts can advantageously support the electrochemical oxidation by its function as supporting electrolyte
These salts of high commercial availability, favorable in view of ecological and working hazards and of costs
As mentioned below, it is believed that t- butyl hydroperoxide has also a mediator function in the electrochemical oxidation process.
It is a particular advantage that the above process can be performed without an additional mediator, i.e. without any mediator which is not that t- butyl hydroperoxide.
The concentration of the supporting electrolyte in the reaction medium is preferably up to 5 mol/L (M), more preferably from 0.01 M to 4 M, even more preferably from 0.01 M to 3 M, the most preferably from 0.01 M to 1 .5 M.
The compound t-butyl hydroperoxide is commercially available from different sources.
The compound t- butyl hydroperoxide has a function as an oxygen source. Furthermore, it is believed that t- butyl hydroperoxide has also a mediator function in the electrochemical oxidation process.
Preferably, t- butyl hydroperoxide is included in the reaction medium in an amount of from 0.1 vol.-% to 20 vol.-%, preferably from 0.5 vol.-% to 15.0 vol.-%, more preferably from 1 .0 vol.-% to 10 vol.-%, such as 1 vol.-%, 2 vol.-%, 3 vol.-%,
3.5 vol.-%, 4 vol.-%, 4.5 vol.-%, 5 vol.-%, 5.5 vol.-%, 6 vol.-%, 6.5 vol.-%, 7 vol.-%,
7.5 vol.-%, 8 vol.-%, 8.5 vol.-%, 9 vol.-%, 9.5 vol.-% and 10 vol.-%.
In one preferable embodiment, t-butyl hydroperoxide is included in the reaction medium in an amount of from 1 .0 vol.-% to 10 vol.-%, preferably from 2.0 vol.-% to 7.5 vol.-%, more preferably from 4.0 vol.-% to 6.0 vol.-% such as 4.0 vol.-%, 4.5 vol.-% and 5.0 vol.-%.
Preferably, the molar ratio of t-buty I hydroperoxide I compound of the formula (II) is preferably in the range of 1 :1 to 10:1 , more preferably 1.1 :1 to 8:1 , even more preferably 1 .5:1 to 5:1 . It is most preferred that of molar ratio of t-butyl hydroperoxide/compound of formula (II) is 2.5:1 to 4.5:1 .
Optionally, another additional oxygen source (in combination with t-butyl hydroperoxide) could be used, but it is not needed.
Particularly preferred the process is performed in the absence of oxygen, hydrogen peroxide or any peroxide different from t-buty I hydroperoxide, parti-
cularly in the absence of hydrogen peroxide or any peroxide different from t-butyl hydroperoxide.
The compound of the formula (II) may be added into the reaction medium preferably in an amount of from 0.1 mmol/L (mM) to 100 mM, preferably from 0.2 mM to 75 mM, more preferably from 0.2 mM to 50 mM.
For this electrochemical oxidation process, the transferred charge (Q) for the electrochemical oxidation is preferably 10 Faraday (F) or less. A suitable range is particularly 1 -15 F, preferred is 1.5-10 F; more preferred is 1.5-9 F; most preferred is 1 .5-8 F such as 2, 3, 4, 5, 6, 7 and 8 F.
For this electrochemical oxidation process, the current density (/) used in the electrochemical oxidation may be preferably from 0.1 mA/cm2 to 100 mA/cm2, preferably from 0.3 mA/cm2 to 50 mA/cm2, preferably from 0.5 mA/cm2 to 20 mA/cm2.
The described electrochemical oxidation can be carried out in Galvano- static or potentiostatic mode. Depending on the cell, the electrochemical oxidation according to the present invention can be carried out batch-wise, semi-batch-wise, or in a continuous way, preferably in a continuous way.
Therefore, in one embodiment, the electrochemical oxidation is preferably carried out in galvanostatic mode.
In another embodiment, the electrochemical oxidation is preferably carried out in potentiostatic mode
In another embodiment, the electrochemical oxidation is preferably carried out carried out batch-wise.
In another embodiment, the electrochemical oxidation is preferably carried out carried out batch-wise.
In another embodiment, the electrochemical oxidation is preferably carried out carried out semi-batch-wise.
In another embodiment, the electrochemical oxidation is preferably carried out carried out in a continuous way.
The electrochemical oxidation is preferably carried out at a temperature range of from 10 °C to 75 °C, preferably from 15 °C to 60 °C, more preferably at ambient temperature (23°C).
The electrochemical oxidation is preferably carried out at ambient pressure (1013 hPa).
It has been found that said process is preferably performed in the presence of a base, particularly in the presence of an organic base, most preferably in the presence of pyridine.
It is preferred that the molar ratio of pyridine/compound of formula (II) is in the range of 1 :1 to 10:1 , more preferably 1 .1 :1 to 8:1 , even more preferably 1 .5:1 to 5:1 . It is most preferred that of molar ratio of pyridine/compound of formula (II) is 2.5:1 to 3.5:1 .
Particularly advantageous is, that the above process can be performed in the absence of any N-oxide derivatives, such as TEMPO ((2,2,6,6-tetramethyl- piperidin-1 -yl)oxyl) or N-hydroxyphthalimide derivatives. These compounds have significant hazard properties and particularly the use of N-hydroxyphthalimide derivatives is highly controversial and, leading to the fact that for example the use of tetrachloro-N-hydroxyphthalimide is banned in Europe.
It has been, furthermore, observed that the above process can be performed in the absence of any transition metals salts. This is very advantageous as transition metals, particularly soluble transition metals are difficult to recycle from the reaction mixture and/or are disadvantageous in view of ecological point of view.
The big advantage that the electrochemical oxidation can be performed as described above, particularly in the absence of a variety of substances, which are typically required to be present for electrochemical oxidations, is significant as only a low number of ingredients need to be mixed, and the different ingredients of a less complex mixture can be can separated more easily from a reaction mixture after that the reaction has occurred, particularly when the reaction has such high conversion, yield and selectivity as enabled by the present process.
This reaction is particularly interesting for the industrial production of the compounds (I) from the compound of the formula (II) as described above in great details.
As pointed above, a key element of this process is the use of t-buty I hydroperoxide for the above process.
Hence, in a further aspect, the present invention relates the use of t-buty I hydroperoxide in the electrochemical oxidation of a compound of the formula (II).
The compound of the formula (II), its preferred embodiments as well the details of said use, particularly the conditions and presence resp. absence of further ingredients are disclosed above in great detail for the process for preparing a compound of the formula (I).
Examples
The present invention is further illustrated by the following experiments.
General Example
The undivided Teflon cells used for electrolysis were purchased from IKA (IKA-Werke GmbH & Co. KG, Staufen, Germany). The dimensions of the electrodes are 7 cm x 1 cm x 0.3 cm.
In an undivided 7 mL Teflon pot cell, the 2-butanone (5 mL) is presented and then sodium tetrafluoroborate or lithium perchlorate, t-butyl hydroperoxide, pyridine and a compound of formula (II) are dissolved (further details see table 1 ). The cell is equipped with vitreous carbon electrodes at a distance of 0.5 cm. The immersion area of the electrodes is 1 .8 cm2. Stirring rate is 400 rpm. After the cell is fixed in a stainless steel block, galvanostatic electrolysis is performed with a current density as given in table 1 at 25 °C.
1 NaBF4= sodium tetrafluoroborate; LPC=lithium perchlorate=LiCIO4
2 Py=pyridine 3 ©HP=t-butyl hydroperoxide
4 Q = transferred charge 5j = current density
After completion of the reaction, the reaction was processed with a saturated, aqueous NaCI solution and extracted three times with ethyl acetate. The organic phase was dried over sodium sulfate, filtered and removed under reduced pressure. Subsequently, the corresponding ketone of the formula (I) was obtained after column chromatographic purification. The yield is given in table 1 .
Claims
1 . A process for preparing a compound of the formula (I) by electrochemical oxidation of a compound of the formula (II)
in the presence of t-butyl hydroperoxide, characterized in that
R1 represents either
OR or a Ci -10-alkyl group which optionally is olefinic or carries at least a carbonyl or hydroxyl group; and
R2 represents H;
R3 and R4, independently from each other, represent either H or a methyl group;
R7 and R8, independently from each other, represent either H or a methyl group;
2. The process according to claim 1 characterized in that R2 = H.
3. The process according to claim 1 or 2 characterized in that R1 a substituent of the formula (III)
wherein R5 represents either H or CHs or CH2CH3 or OH and
5. The process according to any of the preceding claims, characterized in that R3=R4=CH3.
6. The process according to any of preceding claims characterized in that R represents R' which is an acyl group, particularly an acetyl group or a benzoyl group.
7. The process according to any of preceding claims characterized in that the process is performed in the presence of a base, particularly in the presence of an organic base, most preferably in the presence of pyridine.
8. The process according to any of preceding claims characterized in that the process is performed in the presence of an alkali salt of tetrafluoroborate, particularly of sodium tetrafluoroborate.
9. The process according to any of preceding claims characterized in that the process is performed in the absence of any additional mediator, particular in the absence of any N-oxide derivatives or N-hydroxyphthalimide derivatives.
10. The process according to any of preceding claims characterized in that the process is performed in the absence of any transition metals salts.
11 . The process according to any of preceding claims characterized in that the process is performed in the absence of hydrogen peroxide or any peroxide different from t-butyl hydroperoxide.
12. The process according to any of preceding claims characterized in that the process is performed in water or a non-aqueous solvent or mixture thereof, preferably in a non-aqueous organic solvent, particularly selected from the group consisting of alkylene carbonates, dialkylcarbonates, polyethylene glycol, N-methyl-2-pyrrolidone, N-butylpyrrolidone (NBP), alcohols, esters, ketones, particularly acetone and 2-butanone; acetic acid, sulpholane, dimethylsulphoxide (DMSO), tetrahydrofuran (THF), 2-methyl-tetrahydro- furan (MeTHF), dimethylformamide (DMF), hexa-methylphosphoramide, acetonitrile (MeCN), dichloromethane (DCM), dimethoxyethane (DME) and hexafluoro-2-propanol, and mixtures thereof.
13. The process according to any of preceding claims characterized in that the compound of the formula (II) is selected from the group consisting of pregnenolone, and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting of pregnenolone, pregnenolone acetate and pregnenolone benzoate.
14. The process according to any of preceding claims characterized in that the compound of the formula (II) is selected from the group consisting of cholesterol, stigmasterol, campesterol, -sitosterol, brassicasterol, 25- hydroxycholesterol, 24-hydroxycholesterol, lanosterol and the esters thereof with a carboxylic acid having 1 to 7 carbon atoms; preferably selected from the group consisting cholesterol, 25- hydroxycholesterol, cholesteryl acetate, 25-hydroxycholesteryl acetate, cholesteryl benzoate and 25-hydroxycholesteryl benzoate, more preferably cholesterol or 25-hydroxycholesterol.
15. Use of t-butyl hydroperoxide in the electrochemical oxidation of a compound of the formula (II)
characterized in that R1 represents either
OR or a Ci -io-alkyl group which optionally is olefinic or carries at least a carbonyl or hydroxyl group; and
R2 represents H;
R3 and R4, independently from each other, represent either H or a methyl group; R7 and R8, independently from each other, represent either H or a methyl group;
R represents hydrogen or R' which is a protecting group with the proviso that if R7 = R8 = methyl the double bond in formula (I) and
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP23180800.7 | 2023-06-22 | ||
EP23180800 | 2023-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024261183A1 true WO2024261183A1 (en) | 2024-12-26 |
Family
ID=86942857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2024/067339 WO2024261183A1 (en) | 2023-06-22 | 2024-06-20 | Electrochemical oxidation of compounds having allylic c-h bonds to yield alpha,beta-unsaturated ketones |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024261183A1 (en) |
-
2024
- 2024-06-20 WO PCT/EP2024/067339 patent/WO2024261183A1/en unknown
Non-Patent Citations (1)
Title |
---|
EVAN J. HORN ET AL: "Scalable and sustainable electrochemical allylic C-H oxidation", NATURE, vol. 533, no. 7601, 20 April 2016 (2016-04-20), pages 77 - 81, XP055542428, DOI: 10.1038/nature17431 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2668250B1 (en) | Production of fuel from chemicals derived from biomass | |
Nematollahi et al. | Electrochemical study of catechol and 4-methylcatechol in methanol. Application to the electro-organic synthesis of 4, 5-dimethoxy-and 4-methoxy-5-methyl-o-benzoquinone | |
Wang et al. | Electrosynthesis of cyclic carbonates from CO2 and diols in ionic liquids under mild conditions | |
CN103842555A (en) | Method for producing vanillin by electrochemically oxidizing aqueous lignin solutions or suspensions | |
US10787748B2 (en) | Process for the preparation of an aromatic dicarboxylic acid | |
JP7612585B2 (en) | Oxidation of 5-hydroxy-2-furanone to form maleic ester | |
CN110777391B (en) | Electric reduction preparation method of gefitinib intermediate | |
WO2024261183A1 (en) | Electrochemical oxidation of compounds having allylic c-h bonds to yield alpha,beta-unsaturated ketones | |
US10435799B2 (en) | Process for the purification of a carboxylic acid-containing composition | |
Smeyne et al. | Electrochemical esterification via oxidative coupling of aldehydes and alcohols | |
WO2024261178A1 (en) | Electrochemical oxidation of allylic c-h bonds | |
CN118974324A (en) | Electrochemical oxidation of cycloalkanes to form cycloalkanone compounds | |
Rocek et al. | Evidence for epoxides as intermediates in the chromic acid oxidation of olefins | |
Tajima et al. | Anodic acyloxylation based on the acid–base reactions between acetic acid or trifluoroacetic acid and solid-supported bases | |
Huang | Functionalized acidic ionic liquid with morpholinium cation: synthesis, characterization and catalysis performance in esterification | |
Pardini et al. | Anodic methoxylation of cinnamate esters | |
JPS63176487A (en) | Production of oxatetramethylene dicarboxylic acid | |
Boni et al. | Preparation of 2, 2-Dihalocarboxylic Acid Methyl Esters by Oxidation-Chlorination of 2-(1-Haloalkyl)-4-methyl-1, 3-dioxolanes with Trichloroisocyanuric Acid. | |
CN110172710A (en) | A kind of method that the electrochemistry dechlorination of trichloromethyl pyridine derivative prepares carboxylic esters | |
CN113308704B (en) | Electrooxidative preparation method of naproxen intermediate | |
Tanaka et al. | Electrooxidative Fission of Carbon-Carbon Double Bond in a K2OsO2 (OH) 4/HIO4 Double Mediatory System. | |
CN114540843B (en) | Electrochemical synthesis method of sulfenamide compound | |
JPS6249356B2 (en) | ||
Maurice et al. | Electrochemical Reduction in an Aprotic Medium of New Functionalized Amphiphilic Molecules Derived from Sugars: Stereoselective Pinacolization and an Example of a Glycosidic Carbon‐Oxygen Bond Cleavage | |
Torii et al. | Anodic Ring Opening Reaction of 2-Methoxy-1-cyclopentene-1-carboxylic Acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24735968 Country of ref document: EP Kind code of ref document: A1 |